# Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

> **NCT00347399** · PHASE2 · TERMINATED · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 25 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** bevacizumab intravitreal injection
- **PROCEDURE:** verteporfin photodynamic therapy

## Key facts

- **NCT ID:** NCT00347399
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2006-06-30
- **Final completion:** 2007-06-30
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** undefined
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00347399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00347399, "Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00347399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*